Leukodystrophy

5,283views

Leukodystrophy

NMSK 2022

NMSK 2022

Anatomical terminology
Introduction to the central and peripheral nervous systems
Introduction to the somatic and autonomic nervous systems
Development of the axial skeleton
Bones of the vertebral column
Joints of the vertebral column
Muscles of the back
Vessels and nerves of the vertebral column
Anatomy clinical correlates: Bones, joints and muscles of the back
Superficial structures of the neck: Posterior triangle
Deep structures of the neck: Root of the neck
Anatomy clinical correlates: Vessels, nerves and lymphatics of the neck
Bones of the upper limb
Development of the limbs
Fascia, vessels and nerves of the upper limb
Muscles of the hand
Anatomy of the arm
Anatomy of the brachial plexus
Brachial plexus
Bones of the lower limb
Fascia, vessels and nerves of the lower limb
Muscles of the gluteal region and posterior thigh
Compartment syndrome
Sciatica
Bone remodeling and repair
Ectoderm
Skin histology
Skin anatomy and physiology
Skin and soft tissue infections: Clinical
Papulosquamous and inflammatory skin disorders: Pathology review
Eczematous rashes: Clinical
Skin cancer: Pathology review
Skin cancer: Clinical
Bone histology
Skeletal system anatomy and physiology
Bone disorders: Pathology review
Bone tumors: Pathology review
Paget disease of bone
Pediatric bone and joint infections: Clinical
Joint pain: Clinical
Gout
Rheumatoid arthritis
Nervous system anatomy and physiology
Neuromuscular junction and motor unit
Neuromuscular blockers
Skeletal muscle histology
Muscular system anatomy and physiology
Muscle contraction
Sliding filament model of muscle contraction
Muscle spindles and golgi tendon organs
Neuromuscular junction disorders: Pathology review
Muscle weakness: Clinical
Sympathetic nervous system
Parasympathetic nervous system
Adrenergic receptors
Cholinergic receptors
Opioid agonists, mixed agonist-antagonists and partial agonists
Cholinomimetics: Direct agonists
Substance misuse and addiction: Clinical
Pharmacodynamics: Desensitization and tolerance
Bones of the cranium
Anatomy of the cranial base
Anatomy of the orbit
Anatomy of the eye
Photoreception
Fascia and spaces of the neck
Superficial structures of the neck: Anterior triangle
Eye conditions: Inflammation, infections and trauma: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Eye conditions: Retinal disorders: Pathology review
Pharyngeal arches, pouches, and clefts
Development of the face and palate
Development of the nervous system
Anatomy of the brainstem
Broca aphasia
Wernicke aphasia
Memory
Cerebrospinal fluid
Normal pressure hydrocephalus
Anatomy of the blood supply to the brain
Introduction to the cranial nerves
Cranial nerves
Cranial nerve pathways
Spina bifida
Congenital neurological disorders: Pathology review
Meningitis, encephalitis and brain abscesses: Clinical
Meningitis
Brain abscess
Encephalitis
Spinal cord disorders: Pathology review
Sensory receptor function
Somatosensory receptors
Anatomy of the ascending spinal cord pathways
Anatomy of the descending spinal cord pathways
Anatomy clinical correlates: Spinal cord pathways
Somatosensory pathways
Vitamin B12 deficiency
Motor cortex
Pyramidal and extrapyramidal tracts
Brown-Sequard Syndrome
Syringomyelia
Cauda equina syndrome
Myasthenia gravis
Lambert-Eaton myasthenic syndrome
Amyotrophic lateral sclerosis
Olfactory transduction and pathways
Trigeminal neuralgia
Bell palsy
Optic pathways and visual fields
Pituitary adenoma
Anatomy of the oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy clinical correlates: Oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Vestibulo-ocular reflex and nystagmus
Vestibular transduction
Cerebellum
Dizziness and vertigo: Clinical
Basal ganglia: Direct and indirect pathway of movement
Essential tremor
Huntington disease
Parkinson disease
Movement disorders: Pathology review
Anti-parkinson medications
Medications for neurodegenerative diseases
Hypokinetic movement disorders: Clinical
Multiple sclerosis
Leukodystrophy
Sleep
Toxidromes: Clinical
Cerebral vascular disease: Pathology review
Saccular aneurysm
Intracerebral hemorrhage
Arteriovenous malformation
Ischemic stroke
Transient ischemic attack
Anatomy clinical correlates: Posterior blood supply to the brain
Stroke: Clinical
Epidural hematoma
Brain herniation
Traumatic brain injury: Clinical
Traumatic brain injury: Pathology review
Concussion and traumatic brain injury
Adult brain tumors
Brain tumors: Clinical
Cluster headache
Tension headache
Migraine
Cavernous sinus thrombosis
Idiopathic intracranial hypertension
Migraine medications
Antidiuretic hormone
Hypoprolactinemia
Growth hormone and somatostatin
Oxytocin and prolactin
Anatomy of the limbic system
Frontotemporal dementia
Dementia with Lewy bodies
Vascular dementia
Creutzfeldt-Jakob disease
Syncope: Clinical
Amnesia

Transcript

Watch video only

Leukodystrophy can be broken down. Leuko- means “white”, -dys means “abnormal” and -troph means “growth”.

So, leukodystrophy means degeneration of the white matter of the brain, and that’s the part of the cerebral cortex that’s filled with myelinated axons.

Myelin refers to the electrical insulation sheath around axons which allows neurons to quickly send electrical impulses to one another.

Leukodystrophy is a dysmyelinating disease, meaning the structure of the myelin is abnormal, and it’s usually due to a genetic mutation.

In contrast, in a demyelinating diseases, previously normal myelin is damaged, like in multiple sclerosis where the immune cells attack the myelin.

There are many different kinds of leukodystrophy, but the most common ones are Krabbe disease, metachromatic leukodystrophy, and adrenoleukodystrophy.

The cerebral cortex is the largest region of the brain and it’s responsible for sensory and motor functions.

The cerebral cortex has an outer grey area and an inner white area.

The grey area, referred to as grey matter, houses neuron cell bodies.

And the white area, referred to as white matter, houses myelinated axons.

It is lighter because of the high fat content in myelin.

Neurons are the key cells that transmit neural impulses to one another through synapses.

Each neuron has dendrites, a cell body, and an axon.

Dendrites are the branches that first receive a neural impulse at a synapse with another neuron.

The neural impulse passes through the cell body and goes through an axon, which projects information away from the cell body to another cell.

Glial cells are support cells for neurons and they produce myelin to coat the axons.

Myelin is a specialized membrane which helps insulate the axon to make neural impulses travel faster.

Glial cells in the central nervous system, are called oligodendrocytes, and glial cells in the peripheral nervous system are called Schwann cells.

Now the myelin is composed of certain fats, and the primary fat is called galactocerebroside.

Galactocerebroside is also used to make another fat found in myelin called cerebroside sulfatide.

Over time, these fats are broken down by enzymes found within the lysosomes and peroxisomes of the glial cells.

One enzyme that’s found in the lysosome is galactosylceramidase, which is encoded by the GALC gene.

Galactosylceramidase helps break down galactocerebroside as well as a cytotoxic metabolite called psychosine, which is a by-product of myelin production.

Another enzyme that’s in the lysosome is cerebroside-sulfatase, which is encoded by the arylsulfatase A gene, and helps break down cerebroside sulfatide.

An enzyme in the peroxisome is adrenoleukodystrophy, which is encoded by the ABCD1 gene, and helps break down very long chain fatty acids.

Most leukodystrophies are caused by genetic mutations and follow an autosomal recessive inheritance patterns, but some like Adrenoleukodystrophy are X-linked recessive. Let’s go through three of the most common ones.

First off, there’s Krabbe disease, named after the Danish neurologist Knud Krabbe, and it originates from a mutation in the GALC gene, which results in a shortage of galactosylceramidase.

That leads to a buildup of galactocerebroside and psychosine, which damages the glial cells in the central and peripheral nervous system.

Key Takeaways

Leukodystrophy refers to a group of dysmyelinating diseases of the central and peripheral nervous system caused by genetic mutations in enzymes necessary for myelin production. The most common types are metachromatic leukodystrophy, Krabbe disease, and adrenoleukodystrophy. Symptoms are due to neurodegeneration, like decreased motor function, muscular rigidity, and later, blindness and hearing loss.